VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | +87.5% | 1,416 | +95.6% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 724 | -3.7% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 752 | +5.8% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 711 | +19.9% | 0.00% | -100.0% |
| Q2 2020 | $7,000 | -36.4% | 593 | -44.3% | 0.00% | -80.0% |
| Q1 2020 | $11,000 | +1000.0% | 1,064 | +1734.5% | 0.01% | – |
| Q2 2019 | $1,000 | -94.4% | 58 | -94.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +800.0% | 984 | +720.0% | 0.01% | +250.0% |
| Q4 2017 | $2,000 | +100.0% | 120 | +103.4% | 0.00% | +100.0% |
| Q3 2017 | $1,000 | 0.0% | 59 | +20.4% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | -66.7% | 49 | -77.3% | 0.00% | -66.7% |
| Q4 2016 | $3,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |